Table 5.
Univariate and Multivariate Cox regression analysis of metastasis-free survival.
| Univariate Analysis | Multivariate Analysis | |||||
|---|---|---|---|---|---|---|
| Variables | HR | 95% CI | p-value | HR | 95% CI | p-value |
| Disease-free Survival | ||||||
| Age (years) | 0.99 | 0.97–1.03 | 0.954 | |||
| Sex (Male) | 0.94 | 0.54–1.62 | 0.818 | |||
| Open Surgical method | 1.58 | 0.94–2.65 | 0.085 | |||
| Tumor size (cm) | 1.06 | 0.99–1.13 | 0.099 | |||
| Multifocality | 1.76 | 0.75–4.10 | 0.192 | |||
| High grade | 8.32 | 1.15–60.15 | 0.036 | 2.10 | 0.26–17.09 | 0.489 |
| T stage ≥ T2 | 6.16 | 3.02–12.55 | <0.001 | 3.41 | 1.49–7.81 | 0.004 |
| Concomitant CIS | 1.55 | 0.914–2.63 | 0.104 | |||
| Lymphovascular invasion | 6.27 | 3.72–10.56 | <0.001 | 4.21 | 2.42–7.32 | <0.001 |
| eGFR < 60 (mL/min/1.73 m2) | 2.35 | 1.39–3.97 | 0.001 | 1.61 | 0.94–2.77 | 0.086 |
| Urine B2-MG (> 0.3 ug/mL) | 2.18 | 1.29–3.70 | 0.004 | 1.78 | 1.03–3.07 | 0.039 |
CI, confidence interval; CIS, carcinoma in situ; eGFR, estimated glomerular filtration rate.